Page 81 - AI for Good-Innovate for Impact
P. 81

AI for Good-Innovate for Impact



               Use Case – 16: Fusion of nanosecond pulses and artificial

               intelligence: precision medicine innovation in the field of tumor
               ablation                                                                                             16 - Ruidi











               Country: China

               Organization: Hangzhou Ruidi Biological Technology Co., Ltd.

               Contact person: Xinhua Chen (Cindy Chen), xinhua _chen@ zju .edu .cn


               16�1� Use case summary table

                Domain              Health

                The Problem to be   •  Reducing damage to surrounding cells during tumor treatment
                addressed           •  Optimizing treatment effects and reducing postoperative compli-
                                       cations
                                    •  Decreasing mortality and treatment costs

                Key aspects of the   •  Use of nanosecond pulse technology for precise tumor ablation
                solution            •  Integration of Artificial Intelligence (AI) for optimized treatment
                                       planning and intraoperative navigation
                                    •  Targeted tumor management and precise positioning, facilitated by
                                       preoperative image planning and intraoperative navigation.

                Technology          Nanosecond pulse technology, AI for planning and navigation, Posi-
                keywords            tioning, Image processing, Deep Learning
                Data availability   No
                                    Combination of public research and patient data

                Metadata (type of   Image (Pre-operative and treatment), Real-time monitoring data
                data)

                Model Training and   •  Image processing techniques for training
                fine-tuning         •  Ongoing AI model optimization

                Case Studies        None

                Testbeds or pilot   The research and testing phase is still ongoing.
                deployments



               16�2� Use case description


               16�2�1� Description

               Introduction: Tumor ablation, a critical aspect of cancer treatment , often faces challenges in
               achieving precision while minimizing collateral damage to healthy tissues. To address these



                                                                                                     65
   76   77   78   79   80   81   82   83   84   85   86